Free Standard Canada-Wide Delivery (Orders $150+)

Retatrutide 30 mg

C$239.99
In stock: 16 available
Product Details
Brand: Helix Havoc Labs

Requires Reconstitution:

Peptide Calculator available for concentration reference (opens in a new tab).


Supplies used for reconstitution include bacteriostatic water and sterile handling supplies (sold separately).


RETATRUTIDE 30 MG

Retatrutide is a next-generation triple-agonist research peptide studied for its activity across GLP-1, GIP, and glucagon receptor pathways. Its multi-receptor profile makes it valuable for controlled studies involving metabolic modeling, nutrient signaling, adipose-tissue behavior, and appetite-related receptor interactions.


Research Focus Areas:

• Multi-pathway metabolic signaling
• Adipose-tissue and energy-balance modeling
• Appetite-regulation pathway studies
• Nutrient-partitioning research
• Triple-agonist receptor behavior modeling


Specifications:

Purity: ≥99% (independent third-party analytical testing)
Form: Lyophilized peptide
Solvent: Not included
Use: Laboratory research only
Storage: Refrigerate; protect from light and moisture
Handling: Suitable for in-vitro experimentation and analytical applications
Compliance: Not for human use. No medical or therapeutic claims.

Batch-specific analytical documentation is available in the COA tab.

Also referenced in research as: Reta


Share this product with your friends

Most Requested by Researchers